ICH E2D
E559691
ICH E2D is an International Council for Harmonisation guideline that provides standards for post-approval safety data management, including the collection, evaluation, and reporting of safety information for marketed medicinal products.
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
ICH guideline
ⓘ
pharmacovigilance guideline ⓘ |
| abbreviationOf | International Council for Harmonisation Guideline E2D NERFINISHED ⓘ |
| addresses |
definitions related to post-approval safety data
ⓘ
expedited reporting time frames ⓘ follow-up of safety reports ⓘ literature case reporting ⓘ minimum information for a valid individual case safety report ⓘ reporting of safety information from compassionate use or named-patient programs ⓘ reporting of safety information from non-interventional studies ⓘ reporting of safety information from post-authorization studies ⓘ reporting of safety information from registries ⓘ reporting of safety information from special situations such as pregnancy and overdose ⓘ unlisted and serious adverse reactions ⓘ |
| appliesTo |
clinical trial safety reports after marketing authorisation
ⓘ
marketed medicinal products ⓘ post-marketing individual case safety reports ⓘ spontaneous reports of adverse drug reactions ⓘ |
| covers |
company and regulatory responsibilities for safety data management
ⓘ
data quality and completeness in safety reports ⓘ electronic and paper-based safety reporting ⓘ handling of duplicate reports ⓘ |
| defines |
criteria for expedited reporting of individual case safety reports
ⓘ
standards for collection of post-marketing safety data ⓘ standards for evaluation of post-marketing safety data ⓘ standards for reporting of post-marketing safety data ⓘ |
| domain |
drug safety regulation
ⓘ
pharmacovigilance ⓘ |
| focusesOn |
expedited reporting of safety information
ⓘ
post-approval safety data management ⓘ safety information for marketed medicinal products ⓘ |
| fullName | ICH Harmonised Tripartite Guideline E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting NERFINISHED ⓘ |
| issuedBy | International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use NERFINISHED ⓘ |
| objective |
to harmonise international standards for post-approval safety reporting
ⓘ
to improve consistency of expedited safety reporting across regions ⓘ to support protection of public health through timely safety communication ⓘ |
| regulatoryRegion |
European Union
NERFINISHED
ⓘ
ICH regions ⓘ Japan NERFINISHED ⓘ United States NERFINISHED ⓘ |
| relatedTo |
ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
NERFINISHED
ⓘ
ICH E2B Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports NERFINISHED ⓘ ICH E2C Periodic Benefit-Risk Evaluation Report (PBRER) NERFINISHED ⓘ ICH E2E Pharmacovigilance Planning NERFINISHED ⓘ |
| status | harmonised guideline ⓘ |
| usedBy |
marketing authorisation holders
ⓘ
pharmaceutical companies ⓘ regulatory authorities ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.